Concepedia

Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization

Shih–Fan Kuan, Sarah Navina, Kristi L. Cressman, Reetesh K. Pai

Human Pathology · 2013 · 60 citations · 24 references

DOI

Concepts

References

24

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

Daniel J. Weisenberger, Kimberly D. Siegmund, Mihaela Campan et al. · Nature Genetics · 2006 · 2K citations

, , +17

Wild-Type <i>BRAF</i> Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer

Federica Di Nicolantonio, Miriam Martini, Francesca Molinari et al. · Journal of Clinical Oncology · 2008 · 1.6K citations · Full text

, , +17

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

David Capper, Matthias Preusser, Antje Habel et al. · Acta Neuropathologica · 2011 · 472 citations

, , +9

Frequency of <i>KRAS</i>, <i>BRAF</i>, and <i>NRAS</i> mutations in colorectal cancer

Cecily P. Vaughn, Scott D. ZoBell, Larissa V. Furtado et al. · Genes Chromosomes and Cancer · 2011 · 378 citations

, , +17

CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies

Shuji Ogino · Gut · 2006 · 363 citations · Full text

, , +17